Canaccord Genuity Maintains Buy on TELA Bio, Maintains $12 Price Target
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Caitlin Cronin reaffirms a Buy rating for TELA Bio with a $12 price target.
October 04, 2024 | 3:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity analyst Caitlin Cronin reaffirms a Buy rating for TELA Bio with a $12 price target, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and a specific price target of $12 by Canaccord Genuity suggests positive sentiment and confidence in TELA Bio's future performance. This is likely to have a positive short-term impact on the stock price as investors may view this as a strong endorsement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100